Catalyst Wire Dossier Catalyst Wire Dossier

FF-3 Dry Powder

FF-3 · Autoimmune Technologies, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FF-3 Dry Powder, covering 2017-08-14 to 2017-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain [Phase 2]

See pricing